Attached files
| file | filename |
|---|---|
| 10-K - 10-K - VERTEX PHARMACEUTICALS INC / MA | a2196377z10-k.htm |
| EX-31.1 - EXHIBIT 31.1 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-31_1.htm |
| EX-32.1 - EXHIBIT 32.1 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-32_1.htm |
| EX-21.1 - EXHIBIT 21.1 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-21_1.htm |
| EX-31.2 - EXHIBIT 31.2 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-31_2.htm |
| EX-10.43 - EXHIBIT 10.43 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-10_43.htm |
| EX-10.58 - EXHIBIT 10.58 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-10_58.htm |
| EX-10.59 - EXHIBIT 10.59 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-10_59.htm |
| EX-10.42 - EXHIBIT 10.42 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-10_42.htm |
| EX-10.33 - EXHIBIT 10.33 - VERTEX PHARMACEUTICALS INC / MA | a2196377zex-10_33.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 33-48030, 33-48348, 33-65472, 333-65666, 33-93324, 333-12325, 333-27011, 333-56179, 333-65664, 333-79549, 333-104362, 333-115458, 333-134482, 333-147277, 333-150946, 333-150945 and 333-160442, and Form S-3 No. 333-153543) of Vertex Pharmaceuticals Incorporated of our reports dated February 19, 2010, with respect to the consolidated financial statements of Vertex Pharmaceuticals Incorporated and the effectiveness of internal control over financial reporting of Vertex Pharmaceuticals Incorporated, included in this Annual Report (Form 10-K) for the year ended December 31, 2009.
|
|
/s/ Ernst & Young LLP |
|
|
|
|
|
|
|
Boston, Massachusetts |
|
|
February 19, 2010 |
|